What Rebif 44?
What Rebif 44?
Rebif is a prescription medicine used to treat the symptoms of Multiple Sclerosis. Rebif may be used alone or with other medications. Rebif belongs to a class of drugs called Immunomodulators; Multiple Sclerosis Treatments.
How is Rebif dosed?
The recommended dose of REBIF is either 22 mcg or 44 mcg injected subcutaneously three times per week. REBIF should be administered, if possible, at the same time (preferably in the late afternoon or evening) on the same three days (e.g., Monday, Wednesday, and Friday) at least 48 hours apart each week.
How much does Rebif cost without insurance?
How much does Rebif Rebidose cost without insurance? The price of Rebif Rebidose is $9,303.155 for uninsured customers. Rebif Rebidose costs $8,263.39 using a SingleCare savings card welcomed at participating pharmacies across the country.
Is Avonex the same as Rebif?
Although Avonex and Rebif are similar and both contain interferon beta-1a, they aren’t interchangeable. They’re injected differently, dosed differently, and they have a different frequency or pattern of dosing.
Is Rebif an immunosuppressant?
Rebif is considered an immunosuppressant because it affects how the immune system works and is thought to work by stopping the immune system from attacking the myelin sheath. It may also be called a disease-modifying drug.
What type of Med is Rebif?
Indication: Rebif® is a prescription medicine used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Can Rebif damage your liver?
Liver effects. Liver effects, including liver damage, have been reported in people taking Rebif. In fact, changes in blood levels of liver enzymes are a common side effect of the drug.
Does Rebif cause weight gain?
Changes in weight, such as weight gain or weight loss, haven’t been reported as common side effects of Rebif. However, weight changes may be a sign of liver damage, which is a possible side effect of Rebif.
How effective is Rebif?
Rebif is a moderately effective (category 1.1) DMD; in clinical trials people taking Rebif had about 30% fewer relapses than people taking placebo. In clinical trials, MRI scans showed people taking Rebif had fewer, smaller or no new areas of active MS (lesions).
What company makes Rebif?
EMD Serono and Pfizer Announce FDA Approval of Rebif® Rebidose® (interferon beta-1a) | Pfizer.
What is the recommended dose of Rebif?
The recommended dose of REBIF is either 22 mcg or 44 mcg injected subcutaneously three times per week.
How many MCG are in a Rebif titration pack?
A Titration Pack containing 6 doses of 8.8 mcg (0.2 mL) and 6 doses of 22 mcg (0.5 mL) is available for use during the titration period in both REBIF prefilled syringes and REBIF Rebidose autoinjectors.
How common are injection site reactions in Rebif-treated patients?
In controlled clinical trials, injection site reactions occurred more frequently in Rebif-treated patients (92% in the 44 mcg group and 89% in the 22 mcg group) than in placebo-treated patients (39%) and at a higher frequency in Rebif treated patients (83%) than in AVONEX-treated patients (28%).
Can a patient self-administer Rebif?
If a patient is to self-administer REBIF, the physical and cognitive ability of that patient to self-administer and properly dispose of prefilled syringes or the REBIF Rebidose autoinjectors should be assessed. Patients with severe neurological deficits should not self-administer injections without assistance from a trained caregiver.
